Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-02 Kelly James Patrick EVP & Chief Financial Officer Sale −9,155 $15.35 $140K 168,066
2018-01-02 Kelly James Patrick EVP & Chief Financial Officer Exercise or conversion · Restricted Stock Unit −5,000 0
2018-01-02 Kelly James Patrick EVP & Chief Financial Officer Exercise or conversion · Restricted Stock Unit −5,000 5,000
2018-01-02 Kelly James Patrick EVP & Chief Financial Officer Exercise or conversion · Restricted Stock Unit −7,500 15,000
2018-01-02 Gulino Richard L. SVP, General Counsel & Sec. Exercise or conversion +12,500 76,600
2018-01-02 Gulino Richard L. SVP, General Counsel & Sec. Exercise or conversion +7,500 99,100
2018-01-02 Gulino Richard L. SVP, General Counsel & Sec. Sale −10,367 $15.20 $158K 88,733
2018-01-02 Gulino Richard L. SVP, General Counsel & Sec. Exercise or conversion · Restricted Stock Unit −12,500 25,000
2018-01-02 Gulino Richard L. SVP, General Counsel & Sec. Exercise or conversion · Restricted Stock Unit −7,500 15,000
2018-01-02 Birznieks Gunther SVP, Business Development Sale −8,568 $15.26 $131K 118,366
2017-12-28 Polymeropoulos Mihael Hristos President and CEO Gift −10,000 1,031,848
2017-06-15 Watkins Thomas Director Grant or award +5,000 5,000
2017-06-15 Watkins Thomas Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-06-15 MILANO VINCENT Director Grant or award +5,000 5,000
2017-06-15 MILANO VINCENT Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-06-15 DUGAN RICHARD W Director Grant or award +5,000 10,770
2017-06-15 DUGAN RICHARD W Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-06-15 COLA MICHAEL F Director Grant or award +5,000 5,000
2017-06-15 COLA MICHAEL F Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-06-15 BATE KENNETH Director Grant or award +5,000 5,000

Page 21 of 36 · 717 trades